Tranexamic Acid Injection, Solution
Product Images NDC 14789-115

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 14789-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tra16 0001 01)

Structural Formula (Tra16 0001 01)
Chemical structure diagram of tranexamic acid, showing a cyclohexane ring bonded to an amino group and a carboxylic acid functional group.*
FDA Label Image

Figure (Tra16 0001 02)

FDA Label Image

Principal Display Panel – 100 mL Bag Label (Tra16 0001 03)

Principal Display Panel – 100 mL Bag Label (Tra16 0001 03)
Label for Tranexamic Acid Injection, 10 mg/mL in 0.7% Sodium Chloride, provided as a 100 mL single-dose intravenous infusion solution. The label includes cautions, storage instructions, and manufacturer Nexus Pharmaceuticals LLC. It states the product is sterile, unpreserved, nonpyrogenic, made in the UK, and for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.